Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Henriksson

Showing results (101-110 of 137) with videos related to

Pageof 14
Sort By:
Acta Paediatrica Scandinavica|March 1, 1971
Giant haemangioma with a disorder of coagulationP Henriksson, I M Nilsson, S E Bergentz, et al.
Journal of Internal Medicine|March 6, 1998
Intravenous nitroglycerin reduces ischaemia in unstable angina pectoris: a double-blind placebo-controlled studyK E Karlberg, T Saldeen, R Wallin, et al.
Biochemical and Biophysical Research Communications|April 5, 1996
Dietary cholesterol induces transient changes in plasma nitrate levels in rabbits that are correlated to microcirculatory changesA Freyschuss, R J Xiu, G Benthin, et al.
Lakartidningen|October 14, 1992
[Parenteral estrogen--a safe therapeutic alternative in prostatic cancer seen from the cardiovascular point of view?]P Henriksson, R Stege, L Collste, et al.
The Journal of Clinical Investigation|June 1, 1994
The antioxidant butylated hydroxytoluene prevents early cholesterol-induced microcirculatory changes in rabbitsR J Xiu, A Freyschuss, X Ying, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|January 1, 1991
The antioxidant butylated hydroxytoluene protects against atherosclerosisI Björkhem, A Henriksson-Freyschuss, O Breuer, et al.
British Journal of Haematology|January 1, 1980
A specific, fluorescent activity staining procedure applied to plasma and red blood cells in congenital factor XIII deficiencyP Henriksson, P Stenberg, I M Nilsson, et al.
Urologia Internationalis|January 1, 1987
Serum prolactin assays have no prognostic value in treatment of prostatic cancer by orchidectomy or estrogensR Stege, K Carlström, A Eriksson, et al.
The Prostate|May 15, 1997
Possible bone-preserving capacity of high-dose intramuscular depot estrogen as compared to orchidectomy in the treatment of patients with prostatic carcinomaK Carlström, R Stege, P Henriksson, et al.
Pediatric Research|September 1, 1974
Fibrin-stabilizing factor (factor XIII) in the fetus and the newborn infantP Henriksson, U Hedner, I M Nilsson, et al.
Pageof 14

Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
Acta Paediatrica Scandinavica|March 1, 1971
Giant haemangioma with a disorder of coagulationP Henriksson, I M Nilsson, S E Bergentz, et al.
Journal of Internal Medicine|March 6, 1998
Intravenous nitroglycerin reduces ischaemia in unstable angina pectoris: a double-blind placebo-controlled studyK E Karlberg, T Saldeen, R Wallin, et al.
Biochemical and Biophysical Research Communications|April 5, 1996
Dietary cholesterol induces transient changes in plasma nitrate levels in rabbits that are correlated to microcirculatory changesA Freyschuss, R J Xiu, G Benthin, et al.
Lakartidningen|October 14, 1992
[Parenteral estrogen--a safe therapeutic alternative in prostatic cancer seen from the cardiovascular point of view?]P Henriksson, R Stege, L Collste, et al.
The Journal of Clinical Investigation|June 1, 1994
The antioxidant butylated hydroxytoluene prevents early cholesterol-induced microcirculatory changes in rabbitsR J Xiu, A Freyschuss, X Ying, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|January 1, 1991
The antioxidant butylated hydroxytoluene protects against atherosclerosisI Björkhem, A Henriksson-Freyschuss, O Breuer, et al.
British Journal of Haematology|January 1, 1980
A specific, fluorescent activity staining procedure applied to plasma and red blood cells in congenital factor XIII deficiencyP Henriksson, P Stenberg, I M Nilsson, et al.
Urologia Internationalis|January 1, 1987
Serum prolactin assays have no prognostic value in treatment of prostatic cancer by orchidectomy or estrogensR Stege, K Carlström, A Eriksson, et al.
The Prostate|May 15, 1997
Possible bone-preserving capacity of high-dose intramuscular depot estrogen as compared to orchidectomy in the treatment of patients with prostatic carcinomaK Carlström, R Stege, P Henriksson, et al.
Pediatric Research|September 1, 1974
Fibrin-stabilizing factor (factor XIII) in the fetus and the newborn infantP Henriksson, U Hedner, I M Nilsson, et al.
Pageof 14